Heterohcl · Newsroom
Favivir by Hetero Healthcare for Mild to Moderate Covid-19 is Available Now
HETERO HEALTHCARE Ltd feels proud to distribute and market its second drug to fight against COVID-19 called FAVIVIR under the license from Gilead Sciences. The DCGI has granted accelerated approval of FAVIVIR to meet the urgent medical need.July 30, 2020